Cel-Sci Corp (AMEX:CVM) (was HIV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)

CVM 5.130

-5.7%

Jan 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Shutters who wrote (2690)	9/20/1999 5:27:00 PM
From: Alan Brezin	Read Replies (1) of 2836

The explanation about concerns of releasing information about trials because of the potential of creating false hopes for terminal patients, etc. is the first rational news from Cel-Sci in a long time, imo. Obviously their hands have been tied by trial and established cancer treatment protocols and the results of complete regression described in the release are exciting if transferable to a widespread trial population. However, it appears that there is still a long way to go for approval and commerciality. The facility needed to produce the multikine reminds me of the PRAL lab they had to improvise years ago at great cost of money and time as I recall. This could be another time consuming stumbling block which they didn't discuss in the update. A regular update would be nice if it has substance like this one, imo. Alan Brezin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next